Breaking News Instant updates and real-time market news.

FOLD

Amicus

$8.32

-0.58 (-6.52%)

09:02
11/29/16
11/29
09:02
11/29/16
09:02

Amicus price target lowered to $12 from $15 at Cowen

Cowen analyst Ritu Baral lowered her price target on Amicus to $12 from $15 after the FDA told the company it could not file the Galafold NDA with current data and that data from a new trial is expected in 2019. Baral maintained her Outperform rating on Amicus, stating that the planned GI trial has a good chance of success.

FOLD Amicus
$8.32

-0.58 (-6.52%)

06/14/16
LEER
06/14/16
NO CHANGE
Target $19
LEER
Outperform
Protalix development encouraging for Amicus Galafold, says Leerink
Leerink analyst Joseph Schwartz is "incrementally encouraged" by the news that Protalix (PLX) reached an agreement with the FDA to advance its Fabry ERT into a pivotal trial, just before Amicus' (FOLD) meeting with the agency to discuss a regulatory path for its Galafold. Amicus was poised to emphasize non-renal data in the upcoming FDA meeting, but now the company has "another way to win" by using renal data, the analyst tells investors in a research note. Schwartz now assigns a 33% probability for Galafold. The analyst reiterates an Outperform rating on Amicus' stock and raised his price target on the shares to $19 from $17.
07/20/16
JPMS
07/20/16
NO CHANGE
Target $13
JPMS
Overweight
Amicus risk/reward 'compelling' at current levels, says JPMorgan
JPMorgan analyst Anupam Rama views the risk/reward for shares of Amicus Therapeutics at current levels as "compelling." After declining 39% year-to-date, Amicus is essentially only pricing in outside the U.S. Galafold sales in Fabry disease plus cash, Rama tells investors in a research note. Very little credit is being given to the company's U.S. migalastat, Zorblisa or the Pompe program, which all have events in the second half of 2016, the analyst contends. Rama thinks only one of the three need to hit for the stock to trade "materially higher," with upside ranging from 20%-100%-plus on a single success, and "meaningfully more upside" potential on multiple positive updates. Rama reiterates an Overweight rating on Amicus with a $13 price target.
08/22/16
GSCO
08/22/16
NO CHANGE
GSCO
Goldman lists companies to be in focus after Medivation deal
After Pfizer (PFE) announced it has agreed to acquire Medivation (MDVN) for $81.50 per share in cash, Goldman Sachs analyst Salveen Richter said he expects a focus on other commercial small-to-mid-cap cancer companies, including Incyte (INCY), Seattle Genetics (SGEN), ARIAD (ARIA) and Exelixis (EXEL). Also noting that Sanofi (SNY), which was pursuing Medivation, has recently suggested an interest in a rare disease transaction up to potentially as large as $20B, he would expect rare disease companies of that size - such as BioMarin (BMRN), Amicus (FOLD) and Ultragenyx (RARE) - to be in focus as well.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).

TODAY'S FREE FLY STORIES

FMSA

Fairmount Santrol

$9.27

-0.08 (-0.86%)

17:06
12/07/16
12/07
17:06
12/07/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Fairmount Santrol »

Point72 Asset reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

COVS

Covisint

$2.30

0.1 (4.55%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Covisint signs agreements with SAIC General Motors, NextEV »

Covisint Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$770.19

5.47 (0.72%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Amazon launches menswear brand 'Buttoned Down' »

Amazon announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$32.65

-1.15 (-3.40%)

16:50
12/07/16
12/07
16:50
12/07/16
16:50
Hot Stocks
Breaking Hot Stocks news story on AMC Entertainment »

Monterey Capital III…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCFT

MCBC Holdings

$14.18

0.23 (1.65%)

16:43
12/07/16
12/07
16:43
12/07/16
16:43
Syndicate
MCBC Holdings files to sell 1M shares of common stock for holders »

B. Riley and Co. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.97

-0.03 (-0.17%)

16:42
12/07/16
12/07
16:42
12/07/16
16:42
Syndicate
Eagle Point Credit files to sell 1.15M shares of common stock »

Keefe, Bruyette &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:39
12/07/16
12/07
16:39
12/07/16
16:39
General news
Moody's changes outlook on Italy to negative from stable »

Moody's Investors…

DNB

Dun & Bradstreet

$123.83

2.42 (1.99%)

16:39
12/07/16
12/07
16:39
12/07/16
16:39
Hot Stocks
Dun & Bradstreet appoints CEO Robert Carrigan as chairman »

Dun & Bradstreet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIND

Mitcham Industries

$3.73

0.04 (1.08%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Earnings
Mitcham Industries reports Q3 EPS (62c), consensus (43c) »

Reports Q3 revenue $8.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$13.30

0.09 (0.68%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Hot Stocks
Crescent Point Energy announces $1.45B CapEx budget for 2017 »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$24.58

0.59 (2.46%)

16:34
12/07/16
12/07
16:34
12/07/16
16:34
Hot Stocks
Corning announces $4B share repurchase program »

Corning announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTT

Wireless Telecom Group Inc

$1.58

0.01 (0.64%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Wireless Telecom Group Inc appoints Michael Kandell as CFO »

Wireless Telecom Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$4.85

0.1 (2.11%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Argos announces rocapuldencel-T as generic name for AGS-003 »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WWE

WWE

$19.43

0.48 (2.53%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
WWE co-founder says appointed by Trump to lead Small Business Administration »

Linda McMahon, WWE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPC

W.P. Carey

$59.52

1.08 (1.85%)

16:31
12/07/16
12/07
16:31
12/07/16
16:31
Hot Stocks
W.P. Carey raises quarterly dividend to 99c per share »

W.P. Carey reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CM

CIBC

$83.70

1.28 (1.55%)

, PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Conference/Events
PrivateBancorp to host special shareholder meeting »

Special Shareholder…

CM

CIBC

$83.70

1.28 (1.55%)

PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Options
Preliminary option volume of 21.5M today »

Preliminary option volume…

CMTL

Comtech

$12.75

0.77 (6.43%)

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Comtech declares 10c quarterly dividend, sees FY17 quarterly dividends unchanged »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

SKLN

Skyline Medical

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Nations Advisory Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

River North Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Kodiak Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$21.15

-0.02 (-0.09%)

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Conference/Events
William Blair software/SaaS analyst holds a tech roundtable dinner meeting »

Software/SaaS Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

TYL

Tyler Technologies

$147.73

1.54 (1.05%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Hot Stocks
Tyler Technologies rejects media reports of issues with Odyssey product »

Tyler Technologies issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

HRB

H&R Block

$23.34

0.65 (2.86%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Earnings
H&R Block reports Q2 continuing ops EPS (67c), consensus (68c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TSN

Tyson Foods

$58.82

1.43 (2.49%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Hot Stocks
Tyson incoming CEO Tom Hayes sees growth in retail, foodservice businesses »

Tyson Foods president and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.